Results 11 to 20 of about 421,152 (353)
Stem cell research & therapeutics, 2022 Ischemic stroke is one of the major causes of death and disability in the world. Currently, most patients cannot choose intravenous thrombolysis or intravascular mechanical thrombectomy because of narrow therapeutic windows and severe complications. Stem
Li Zhou +12 more
semanticscholar +1 more source
Journal of Cardiovascular Development and Disease, 2022 Background: Cardiomyopathy is one of the complications associated with diabetes. Due to its high prevalence, diabetic cardiomyopathy has become an urgent issue for diabetic patients.
Wei-Syun Hu +4 more
doaj +1 more source
Effects of bone marrow mesenchymal stem cell transplantation on tumor necrosis factor-alpha receptor 1 expression, granulosa cell apoptosis, and folliculogenesis repair in endometriosis mouse models [PDF]
Veterinary World, 2021 Background and Aim: Endometriosis affects the ovaries and causes a decrease in the oocyte quality during endometrial receptivity. During the development of ovarian follicles, paracrine communication occurs between granulosa cells and oocytes.
Sri Ratna Dwiningsih +7 more
doaj +1 more source
Mesenchymal stem cells in hematopoietic stem cell transplantation [PDF]
Cytotherapy, 2009 Mesenchymal stromal/stem cells (MSC) of bone marrow (BM) origin not only provide the supportive microenvironmental niche for hematopoietic stem cells (HSC) but are capable of differentiating into various cell types of mesenchymal origin, such as bone, fat and cartilage.
Minoo, Battiwalla, Peiman, Hematti
openaire +2 more sources
Mesenchymal stem cells and transplant tolerance [PDF]
Nephrology, 2014 AbstractDifferent strategies are being tried to induce transplant tolerance in clinical settings; however, none of them are both safe and effective. Mesenchymal stem cells have been found to be potent immunomodulators and immunosuppressants. We discuss in this review different sources of mesenchymal stem cells and the potent role of adipose tissue ...
Aruna V, Vanikar +4 more
openaire +2 more sources
Mesenchymal stem cells in transplantation and tissue regeneration [PDF]
Frontiers in Immunology, 2011 Mesenchymal stem cells (MSC) were identified in the 1960s as bone marrow cells capable of osteogenic differentiation (Friedenstein and Petrakova, 1966). In the following decennia, these cells were further attributed with the capacity to differentiate into adipogenic, chondrogenic, and myogenic lineages (Pittenger et al., 1999), to secrete trophic ...
Hoogduijn, Martin J., Dor, Frank J.
openaire +3 more sources
Neural Regeneration Research, 2023 Although many therapeutic interventions have shown promise in treating spinal cord injury, focusing on a single aspect of repair cannot achieve successful and functional regeneration in patients following spinal cord injury .
Xin Sun +10 more
doaj +1 more source
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Cell Proliferation, 2020 Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and microstructural degeneration. The personal and societal costs of osteoporosis are increasing year by year as the ageing of population, posing challenges to public ...
Yu-hua Jiang +4 more
semanticscholar +1 more source
Brain : a journal of neurology, 2020 In this study (trial registration: NCT02166021), we aimed to evaluate the optimal way of administration, the safety and the clinical efficacy of mesenchymal stem cell (MSC) transplantation in patients with active and progressive multiple sclerosis. Forty-
P. Petrou +14 more
semanticscholar +1 more source
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
Biomedicines, 2023 Pancreatic islet transplantation is a therapeutic option for achieving physiologic regulation of plasma glucose in Type 1 diabetic patients. At the same time, mesenchymal stem cells (MSCs) have demonstrated their potential in controlling graft rejection, the most fearsome complication in organ/tissue transplantation.
Serena Barachini +6 more
openaire +4 more sources